1. Home
  2. BLND vs CMPS Comparison

BLND vs CMPS Comparison

Compare BLND & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • CMPS
  • Stock Information
  • Founded
  • BLND 2012
  • CMPS 2020
  • Country
  • BLND United States
  • CMPS United Kingdom
  • Employees
  • BLND N/A
  • CMPS N/A
  • Industry
  • BLND EDP Services
  • CMPS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLND Technology
  • CMPS Health Care
  • Exchange
  • BLND Nasdaq
  • CMPS Nasdaq
  • Market Cap
  • BLND 625.9M
  • CMPS 511.5M
  • IPO Year
  • BLND 2021
  • CMPS 2020
  • Fundamental
  • Price
  • BLND $3.33
  • CMPS $6.31
  • Analyst Decision
  • BLND Buy
  • CMPS Strong Buy
  • Analyst Count
  • BLND 6
  • CMPS 6
  • Target Price
  • BLND $3.58
  • CMPS $47.40
  • AVG Volume (30 Days)
  • BLND 1.6M
  • CMPS 582.9K
  • Earning Date
  • BLND 11-05-2024
  • CMPS 10-31-2024
  • Dividend Yield
  • BLND N/A
  • CMPS N/A
  • EPS Growth
  • BLND N/A
  • CMPS N/A
  • EPS
  • BLND N/A
  • CMPS N/A
  • Revenue
  • BLND $152,122,000.00
  • CMPS N/A
  • Revenue This Year
  • BLND $4.74
  • CMPS N/A
  • Revenue Next Year
  • BLND $25.20
  • CMPS N/A
  • P/E Ratio
  • BLND N/A
  • CMPS N/A
  • Revenue Growth
  • BLND N/A
  • CMPS N/A
  • 52 Week Low
  • BLND $1.15
  • CMPS $5.01
  • 52 Week High
  • BLND $4.25
  • CMPS $12.75
  • Technical
  • Relative Strength Index (RSI)
  • BLND 39.51
  • CMPS 47.21
  • Support Level
  • BLND $3.38
  • CMPS $6.10
  • Resistance Level
  • BLND $3.97
  • CMPS $6.35
  • Average True Range (ATR)
  • BLND 0.19
  • CMPS 0.30
  • MACD
  • BLND -0.03
  • CMPS 0.06
  • Stochastic Oscillator
  • BLND 0.77
  • CMPS 77.89

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: